Search Results - "Elisabetta, Ferraro"

Refine Results
  1. 1

    Chemotherapeutic Drugs and Mitochondrial Dysfunction: Focus on Doxorubicin, Trastuzumab, and Sunitinib by Rosano, Giuseppe, Malara, Natalia, Berrino, L., De Angelis, A., Gorini, Stefania, Ferraro, Elisabetta

    Published in Oxidative medicine and cellular longevity (01-01-2018)
    “…Many cancer therapies produce toxic side effects whose molecular mechanisms await full elucidation. The most feared and studied side effect of chemotherapeutic…”
    Get full text
    Journal Article
  2. 2

    Autophagic and apoptotic response to stress signals in mammalian cells by Ferraro, Elisabetta, Cecconi, Francesco

    Published in Archives of biochemistry and biophysics (15-06-2007)
    “…Autophagy is a highly conserved catabolic programme for degrading proteins and organelles. This process has been shown to act as a pro-survival or pro-death…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Polymeric Systems for the Controlled Release of Flavonoids by Pecorini, Gianni, Ferraro, Elisabetta, Puppi, Dario

    Published in Pharmaceutics (01-02-2023)
    “…Flavonoids are natural compounds that are attracting great interest in the biomedical field thanks to the wide spectrum of their biological properties. Their…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Liquid Biopsy for Cancer Cachexia: Focus on Muscle-Derived microRNAs by Belli, Roberta, Ferraro, Elisabetta, Molfino, Alessio, Carletti, Raffaella, Tambaro, Federica, Costelli, Paola, Muscaritoli, Maurizio

    “…Cancer cachexia displays a complex nature in which systemic inflammation, impaired energy metabolism, loss of muscle and adipose tissues result in…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11

    Molecular control of neuromuscular junction development by Ferraro, Elisabetta, Molinari, Francesca, Berghella, Libera

    Published in Journal of cachexia, sarcopenia and muscle (01-03-2012)
    “…Skeletal muscle innervation is a multi-step process leading to the neuromuscular junction (NMJ) apparatus formation. The transmission of the signal from nerve…”
    Get full text
    Journal Article
  12. 12

    Advance in the Diagnostics and Management of Musculoskeletal Diseases by de Sire, Alessandro, Ferraro, Elisabetta, Leigheb, Massimiliano

    Published in Diagnostics (Basel) (29-06-2022)
    “…Musculoskeletal disorders are a broad spectrum of diseases, affecting muscles, bones, ligaments, and tendons worldwide [...]…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Disease-Modifying Drugs and Breastfeeding in Multiple Sclerosis: A Narrative Literature Review by Capone, Fioravante, Albanese, Angela, Quadri, Giorgia, Di Lazzaro, Vincenzo, Falato, Emma, Cortese, Antonio, De Giglio, Laura, Ferraro, Elisabetta

    Published in Frontiers in neurology (15-04-2022)
    “…Pregnancy-related issues in women with multiple sclerosis (MS) have been receiving increasing attention, with particular interest for the use of…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    Pilocytic Astrocytoma-Derived Cells in Peripheral Blood: A Case Report by Volpentesta, Giorgio, Donato, Giuseppe, Ferraro, Elisabetta, Mignogna, Chiara, Radaelli, Riccardo, Sabatini, Umberto, La Torre, Domenico, Malara, Natalia

    Published in Frontiers in oncology (27-10-2021)
    “…Imaging limitations, invasive tissue biopsies and poor information over the course of treatment to evaluate ‘real-time’ tumor dynamics justify the emerging use…”
    Get full text
    Journal Article
  18. 18

    Bridging Therapies With Injectable Immunomodulatory Drugs in the Management of Multiple Sclerosis: A Delphi Survey of an Italian Expert Panel of Neurologists by Marfia, Girolama Alessandra, Centonze, Diego, Salvetti, Marco, Ferraro, Elisabetta, Panetta, Valentina, Gasperini, Claudio, Mirabella, Massimiliano, Conte, Antonella

    Published in Frontiers in neurology (15-07-2022)
    “…BackgroundIn multiple sclerosis (MS), bridging therapies are usually administered when switching from one therapy to another. Such treatments generally consist…”
    Get full text
    Journal Article
  19. 19

    Metabolic Reprogramming Promotes Myogenesis During Aging by Belli, Roberta, Bonato, Agnese, De Angelis, Luciana, Mirabilii, Simone, Ricciardi, Maria Rosaria, Tafuri, Agostino, Molfino, Alessio, Leigheb, Massimiliano, Costelli, Paola, Caruso, Maurizia, Muscaritoli, Maurizio, Ferraro, Elisabetta

    Published in Frontiers in physiology (10-07-2019)
    “…Sarcopenia is the age-related progressive loss of skeletal muscle mass and strength finally leading to poor physical performance. Impaired myogenesis…”
    Get full text
    Journal Article
  20. 20

    CXCL12 prolongs naive CD4 + T lymphocytes survival via activation of PKA, CREB and Bcl2 and BclXl up-regulation by Laura, Vitiello, Elisabetta, Ferraro, Salvatore, De Simone, Gatta, Lucia, Feraco, Alessandra, Luigi, Racioppi, Giuseppe, Rosano

    Published in International journal of cardiology (01-12-2016)
    “…Abstract Background Naive T lymphocytes recirculate through the body, traveling from secondary lymphoid organs through tissues and via lymphatic vessels and…”
    Get full text
    Journal Article